Literature DB >> 23611749

Molecular and functional characterization of a putative PA28γ proteasome activator orthologue in Schistosoma mansoni.

Cláudia Sossai Soares1, Enyara Rezende Morais, Lizandra G Magalhães, Carla Botelho Machado, Érika Bueno de Carvalho Moreira, Felipe Roberti Teixeira, Vanderlei Rodrigues, Timothy P Yoshino.   

Abstract

PA28γ is a proteasome activator involved in the regulation of the cellular proliferation, differentiation and growth. In the present study, we identified and characterized a cDNA from Schistosoma mansoni exhibiting significant homology to PA28γ of diverse taxa ranging from mammals (including humans) to simple invertebrates. Designated SmPA28γ, this transcript has a 753bp predicted ORF encoding a protein of 250 amino acid residues. Alignment of SmPA28γ with multiple PA28γ orthologues revealed an average similarity of ~40% among the investigated organisms, and 90% similarity with PA28γ from Schistosoma japonicum. In addition, phylogenetic analysis demonstrated a close linkage between SmPA28γ to its sister group that contains well-characterized PA28γ sequences from Drosophila spp., as well as sharing the same branch with PA28γ from S. japonicum. Gene expression profiling of SmPA28γ using real-time quantitative PCR revealed elevated steady-state transcript levels in the eggs, miracidia and paired adult worms compared to other stages. In parallel with gene expression profiles, an affinity-purified anti-SmPA28γ antibody produced against recombinant protein exhibited strongest reactivity in Western blot analyses to endogenous SmPA28γ from miracidia, sporocysts and paired adult worms. Given its known regulatory function in other organisms, we hypothesized that the high level of SmPA28γ transcript and protein in these stages may be correlated with an important role of the PA28γ in the cellular growth and/or development of this parasite. To address this hypothesis, miracidia were transformed in vitro to sporocysts in the presence of SmPA28γ double-stranded RNAs (dsRNAs) and cultivated for 4 days, after which time steady-state transcript and protein levels, and phenotypic changes were evaluated. SmPA28γ dsRNA treatment resulted in gene and protein knockdown of ~60% and ~80%, respectively, which were correlated with a significant decrease in larval length compared to its controls. These findings are consistent with a putative role of SmPA28γ in larval growth/development of the S. mansoni.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23611749      PMCID: PMC3712533          DOI: 10.1016/j.molbiopara.2013.04.003

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  76 in total

Review 1.  The 26S proteasome: a molecular machine designed for controlled proteolysis.

Authors:  D Voges; P Zwickl; W Baumeister
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

Review 2.  Schistosomiasis--a century searching for chemotherapeutic drugs.

Authors:  Gabriela Ribeiro-dos-Santos; Sergio Verjovski-Almeida; Luciana C C Leite
Journal:  Parasitol Res       Date:  2006-04-25       Impact factor: 2.289

Review 3.  Transgenesis of schistosomes: approaches employing mobile genetic elements.

Authors:  V H Mann; M E Morales; K J Kines; P J Brindley
Journal:  Parasitology       Date:  2007-11-09       Impact factor: 3.234

Review 4.  Visualization approaches for multidimensional biological image data.

Authors:  Curtis T Rueden; Kevin W Eliceiri
Journal:  Biotechniques       Date:  2007-07       Impact factor: 1.993

5.  Production of Schistosoma mansoni daughter sporocysts from mother sporocysts maintained in synxenic culture with Biomphalaria glabrata embryonic (Bge) cells.

Authors:  T P Yoshino; J R Laursen
Journal:  J Parasitol       Date:  1995-10       Impact factor: 1.276

Review 6.  Antischistosomal drugs: past, present ... and future?

Authors:  D Cioli; L Pica-Mattoccia; S Archer
Journal:  Pharmacol Ther       Date:  1995       Impact factor: 12.310

Review 7.  The proteasome activator 11 S REG (PA28) and class I antigen presentation.

Authors:  M Rechsteiner; C Realini; V Ustrell
Journal:  Biochem J       Date:  2000-01-01       Impact factor: 3.857

8.  The 26S proteasome in Schistosoma mansoni: bioinformatics analysis, developmental expression, and RNA interference (RNAi) studies.

Authors:  Joseph F Nabhan; Fouad El-Shehabi; Nicholas Patocka; Paula Ribeiro
Journal:  Exp Parasitol       Date:  2007-08-16       Impact factor: 2.011

9.  Activity of 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine against Schistosomiasis mansoni in mice.

Authors:  Sanaa Botros; Samia William; Olfat Hammam; Zdenĕk Zídek; Antonín Holý
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

10.  RNA interference of Schistosoma mansoni cathepsin D, the apical enzyme of the hemoglobin proteolysis cascade.

Authors:  Maria E Morales; Gabriel Rinaldi; Geoffrey N Gobert; Kristine J Kines; Jose F Tort; Paul J Brindley
Journal:  Mol Biochem Parasitol       Date:  2007-11-01       Impact factor: 1.759

View more
  2 in total

1.  Proteasome stress responses in Schistosoma mansoni.

Authors:  Renato Graciano de Paula; Alice Maria de Magalhães Ornelas; Enyara Rezende Morais; Matheus de Souza Gomes; Daniela de Paula Aguiar; Lizandra Guidi Magalhães; Vanderlei Rodrigues
Journal:  Parasitol Res       Date:  2015-02-10       Impact factor: 2.289

2.  Evolution of proteasome regulators in eukaryotes.

Authors:  Philippe Fort; Andrey V Kajava; Fredéric Delsuc; Olivier Coux
Journal:  Genome Biol Evol       Date:  2015-05-04       Impact factor: 3.416

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.